US › Healthcare

Inspira Technologies Oxy BHN Ltd (IINN)

US · Healthcare · Medical Devices

$1.26-21.74%

Last close · 2026-08-04

Latest quarter · ended 2025-09-30

Revenue

$144,500

Net profit

$-3.2M

Profit YoY

-6.3%

EPS

$0.00

EPS estimate

$0.00

Net margin

-2,213.8%

Key statistics

Market cap

$16.6M

Forward P/E

11.8

P/B

28.42

Book value

$0.07

EPS (TTM)

$-0.45

52-week high

$3.85

52-week low

$0.28

50-day MA

$0.50

200-day MA

$0.84

Beta

2.16

Analyst view

Analysts rate Inspira Technologies Oxy BHN Ltd a strong buy (1 buy, 0 hold, 0 sell out of 1) with an average price target of $5.00.

Shareholding

Insiders

10.23%

Institutions

14.80%

Largest institutional holders

Fund	Stake
Armistice Capital, LLC	7.87%
Yorkville Advisors Global, LP	3.76%
Kestra Advisory Services, LLC	0.15%
Susquehanna International Group, LLP	0.11%
XTX Topco Ltd	0.10%
TWO SIGMA SECURITIES, LLC	0.05%
Jane Street Group LLC	0.04%
UBS Group AG	0.03%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Inspira Technologies Oxy BHN Ltd — free to start.

Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc UnitedHealth Group Incorporated Merck & Company Inc Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Novo Nordisk A/S Amgen Inc Abbott Laboratories Gilead Sciences Inc

Data updated 2026-08-05.